Cargando…

An in silico platform for the design of heterologous pathways in nonnative metabolite production

BACKGROUND: Microorganisms are used as cell factories to produce valuable compounds in pharmaceuticals, biofuels, and other industrial processes. Incorporating heterologous metabolic pathways into well-characterized hosts is a major strategy for obtaining these target metabolites and improving produ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatsurachai, Sunisa, Furusawa, Chikara, Shimizu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506926/
https://www.ncbi.nlm.nih.gov/pubmed/22578364
http://dx.doi.org/10.1186/1471-2105-13-93
_version_ 1782250981372723200
author Chatsurachai, Sunisa
Furusawa, Chikara
Shimizu, Hiroshi
author_facet Chatsurachai, Sunisa
Furusawa, Chikara
Shimizu, Hiroshi
author_sort Chatsurachai, Sunisa
collection PubMed
description BACKGROUND: Microorganisms are used as cell factories to produce valuable compounds in pharmaceuticals, biofuels, and other industrial processes. Incorporating heterologous metabolic pathways into well-characterized hosts is a major strategy for obtaining these target metabolites and improving productivity. However, selecting appropriate heterologous metabolic pathways for a host microorganism remains difficult owing to the complexity of metabolic networks. Hence, metabolic network design could benefit greatly from the availability of an in silico platform for heterologous pathway searching. RESULTS: We developed an algorithm for finding feasible heterologous pathways by which nonnative target metabolites are produced by host microorganisms, using Escherichia coli, Corynebacterium glutamicum, and Saccharomyces cerevisiae as templates. Using this algorithm, we screened heterologous pathways for the production of all possible nonnative target metabolites contained within databases. We then assessed the feasibility of the target productions using flux balance analysis, by which we could identify target metabolites associated with maximum cellular growth rate. CONCLUSIONS: This in silico platform, designed for targeted searching of heterologous metabolic reactions, provides essential information for cell factory improvement.
format Online
Article
Text
id pubmed-3506926
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35069262012-11-29 An in silico platform for the design of heterologous pathways in nonnative metabolite production Chatsurachai, Sunisa Furusawa, Chikara Shimizu, Hiroshi BMC Bioinformatics Research Article BACKGROUND: Microorganisms are used as cell factories to produce valuable compounds in pharmaceuticals, biofuels, and other industrial processes. Incorporating heterologous metabolic pathways into well-characterized hosts is a major strategy for obtaining these target metabolites and improving productivity. However, selecting appropriate heterologous metabolic pathways for a host microorganism remains difficult owing to the complexity of metabolic networks. Hence, metabolic network design could benefit greatly from the availability of an in silico platform for heterologous pathway searching. RESULTS: We developed an algorithm for finding feasible heterologous pathways by which nonnative target metabolites are produced by host microorganisms, using Escherichia coli, Corynebacterium glutamicum, and Saccharomyces cerevisiae as templates. Using this algorithm, we screened heterologous pathways for the production of all possible nonnative target metabolites contained within databases. We then assessed the feasibility of the target productions using flux balance analysis, by which we could identify target metabolites associated with maximum cellular growth rate. CONCLUSIONS: This in silico platform, designed for targeted searching of heterologous metabolic reactions, provides essential information for cell factory improvement. BioMed Central 2012-05-11 /pmc/articles/PMC3506926/ /pubmed/22578364 http://dx.doi.org/10.1186/1471-2105-13-93 Text en Copyright ©2012 Chatsurachai et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chatsurachai, Sunisa
Furusawa, Chikara
Shimizu, Hiroshi
An in silico platform for the design of heterologous pathways in nonnative metabolite production
title An in silico platform for the design of heterologous pathways in nonnative metabolite production
title_full An in silico platform for the design of heterologous pathways in nonnative metabolite production
title_fullStr An in silico platform for the design of heterologous pathways in nonnative metabolite production
title_full_unstemmed An in silico platform for the design of heterologous pathways in nonnative metabolite production
title_short An in silico platform for the design of heterologous pathways in nonnative metabolite production
title_sort in silico platform for the design of heterologous pathways in nonnative metabolite production
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506926/
https://www.ncbi.nlm.nih.gov/pubmed/22578364
http://dx.doi.org/10.1186/1471-2105-13-93
work_keys_str_mv AT chatsurachaisunisa aninsilicoplatformforthedesignofheterologouspathwaysinnonnativemetaboliteproduction
AT furusawachikara aninsilicoplatformforthedesignofheterologouspathwaysinnonnativemetaboliteproduction
AT shimizuhiroshi aninsilicoplatformforthedesignofheterologouspathwaysinnonnativemetaboliteproduction
AT chatsurachaisunisa insilicoplatformforthedesignofheterologouspathwaysinnonnativemetaboliteproduction
AT furusawachikara insilicoplatformforthedesignofheterologouspathwaysinnonnativemetaboliteproduction
AT shimizuhiroshi insilicoplatformforthedesignofheterologouspathwaysinnonnativemetaboliteproduction